EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (20 hours ago)
The latest #OpenTox webinar focused on #AOPs current trends and developments, presented by Tatyana Doktorova https://t.co/ZKj5PivfiN
Edelweiss Connect (2 days ago)
RT @barryhardy: Tatyana Doktorova will discuss current trends and developments in Adverse Outcome Pathways as exemplified by case studies (…
Edelweiss Connect (2 weeks ago)
Melanie Fischer, winner of the 2019 3RCC’s 3Rs Award, will present the toxicity test developed to use cultured fish… https://t.co/sDQecx5W2Q
Edelweiss Connect (2 weeks ago)
@EawagResearch researcher Melanie Fischer, winner of the 2019 3RCC’s 3Rs Award, will present the toxicity test deve… https://t.co/KaWTm3ClhT
Edelweiss Connect (2 weeks ago)
Last week's #OpenTox webinar on Trust in cloud-based Safety Assessment #blockchain #cybersecurity #dataintegrity… https://t.co/fHq5zInaEq

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA